These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 17686546)

  • 1. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
    Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
    Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer.
    Li Q; Dong X; Gu W; Qiu X; Wang E
    Chin Med J (Engl); 2003 May; 116(5):727-30. PubMed ID: 12875690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
    Maekawa S; Iwasaki A; Shirakusa T; Enatsu S; Kawakami T; Kuroki M; Kuroki M
    Anticancer Res; 2007; 27(6A):3735-41. PubMed ID: 17970036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells.
    Donnem T; Al-Shibli K; Al-Saad S; Delghandi MP; Busund LT; Bremnes RM
    Lung Cancer; 2009 Feb; 63(2):277-83. PubMed ID: 18599153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
    Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Mylona E; Alexandrou P; Mpakali A; Giannopoulou I; Liapis G; Markaki S; Keramopoulos A; Nakopoulou L
    Eur J Surg Oncol; 2007 Apr; 33(3):294-300. PubMed ID: 17129704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
    Jennbacken K; Vallbo C; Wang W; Damber JE
    Prostate; 2005 Oct; 65(2):110-6. PubMed ID: 15880525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer].
    Li J; Li BL; Zhang HQ; Xu SF; Liu ZD; Yue WT; Han Y
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2982-5. PubMed ID: 19080076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
    Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
    Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
    J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.